Recent studies have shown that
oxytocin reduces food intake and
body weight gain and promotes lipolysis in some species, including humans. Interestingly, these effects of
oxytocin are more marked in obese individuals. Although the menopausal loss of ovarian function induces increased visceral adiposity and some metabolic disorders, no safe medical interventions for these conditions have been established. In this study, we evaluated the effects of
oxytocin on appetite,
body weight, and fat mass in ovariectomized rats. Six-day
oxytocin treatment attenuated cumulative food intake and
body weight gain, and reduced visceral and subcutaneous fat weight and adipocyte cell area in ovariectomized rats. Blood examinations indicated that 6-day
oxytocin treatment did not alter renal or hepatic functions. Instead, it might prevent
ovariectomy-induced liver damage. In addition, acute
oxytocin treatment did not affect body temperature or locomotor activity. These results indicate that
oxytocin might be useful for treating or preventing menopause-induced metabolic disorders, without causing any adverse effects.